Shannon Morris
CIK: 0001973527
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Erasca, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Mar 4, 2026ERAS
Erasca, Inc.
Exercise(M)Direct20K shares at avg. $1.70$34K - Mar 4, 2026ERAS
Erasca, Inc.
Sale(S)Direct20K shares at avg. $15.04$301K - Jan 29, 2026ERAS
Erasca, Inc.
Award(A)DirectStock option (right to buy)
625K shares- - Mar 4, 2025ERAS
Erasca, Inc.
Exercise(M)DirectStock Option (right to buy)
20K shares- - Feb 3, 2025ERAS
Erasca, Inc.
Award(A)DirectStock option (right to buy)
780K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 4, 2026 | ERAS Erasca, Inc. | Exercise(M) | 20,000 | $1.70 | $34,000 | Direct |
| Mar 4, 2026 | ERAS Erasca, Inc. | Sale(S) | 20,000 | $15.04 | $300,760 | Direct |
| Jan 29, 2026 | ERAS Erasca, Inc. | Award(A) Stock option (right to buy) | 625,000 | - | - | Direct |
| Mar 4, 2025 | ERAS Erasca, Inc. | Exercise(M) Stock Option (right to buy) | 20,000 | - | - | Direct |
| Feb 3, 2025 | ERAS Erasca, Inc. | Award(A) Stock option (right to buy) | 780,000 | - | - | Direct |
1-5 of 5 transactions
About Morris Shannon
Morris Shannon (SEC CIK 0001973527) files insider reports with the SEC as Chief Medical Officer of Erasca, Inc. (ERAS).
Signal8 holds 3 ownership filings by Morris Shannon, all Form 4s, filed between Feb 5, 2025 and Mar 6, 2026. Those filings report 5 transactions, from Feb 3, 2025 to Mar 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Morris Shannon's filings is in SAN DIEGO, CA.
Recent filings by Morris Shannon
- Mar 4, 2026: Option exercise of ERAS shares (Form 4, code M).
- Mar 4, 2026: Open-market sale of ERAS shares (Form 4, code S).
- Jan 29, 2026: Grant or award of ERAS derivative securities (Form 4, code A).
- Mar 4, 2025: Option exercise of ERAS derivative securities (Form 4, code M).
- Feb 3, 2025: Grant or award of ERAS derivative securities (Form 4, code A).
Other insiders filing for Erasca, Inc. (ERAS)
- Fuchs Charles S., President, R&D
- Start Valerie Denise Harding, Director
- LIU JEAN I, Director
- Multani Pratik S, Director
- Casdin Alexander W., Director
- Hambleton Julie, Director